| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/26/2000 | EP0973750A1 Substituted benzimidazoles and their use for treating retroviral infection |
| 01/26/2000 | EP0973735A2 Polyaromatic antiviral compositions |
| 01/26/2000 | EP0973727A2 Activated iododerivatives for the treatment of cancer and aids |
| 01/26/2000 | EP0973551A2 Polymeric conjugates polyvalently presenting an agent for therapy |
| 01/26/2000 | EP0973546A2 Stabilized human papillomavirus formulations |
| 01/26/2000 | EP0973527A1 Extended release formulations of erythromycin derivatives |
| 01/26/2000 | EP0973523A1 Anti-microbial product |
| 01/26/2000 | EP0973520A1 Granules comprising clavulanate and one or more excipients |
| 01/26/2000 | EP0973518A1 Semi-synthetic studies toward didemnin analogues |
| 01/26/2000 | EP0973512A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/26/2000 | EP0973510A1 Use of amantadine for treatment of hepatitis c |
| 01/26/2000 | EP0973499A1 Diffusional implantable delivery system |
| 01/26/2000 | EP0973394A1 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO $i(HELICOBACTER PYLORI) AND VACCINE COMPOSITIONS THEREOF |
| 01/26/2000 | CN1242802A Notch protein and their ligands |
| 01/26/2000 | CN1242705A Granules comprising clavulanate and one or more excipients |
| 01/26/2000 | CN1242373A Novel arabinosyladenine derivatives |
| 01/26/2000 | CN1242236A Application of congeners of MIP of HHV8 for preventing and treating aids |
| 01/26/2000 | CN1048719C Novel 7-(substituted)-8-(substituted)-9-(substituted amino)-6-demethyl-6-deoxytetracyclines, prepn. method, their compositions and use thereof |
| 01/25/2000 | US6018054 Intermediate compounds for preparing novel quinolone and naphthyridone derivatives which are substituted in the 7-position by a partially hydrogenated isoindolinyl ring, use as antibacterial agents and as feed additives |
| 01/25/2000 | US6018020 Amino acid derivatives |
| 01/25/2000 | US6018019 Immunogenic synthetic peptides which are useful alone or in conjugates in vaccines against hemophilus influenza infection |
| 01/25/2000 | US6017941 Method of combatting infectious diseases using dicationic bis-benzimidazoles |
| 01/25/2000 | US6017928 Retroviral protease inhibiting compounds |
| 01/25/2000 | US6017927 Quinuclidine derivatives and medicinal composition thereof |
| 01/25/2000 | US6017923 Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents |
| 01/25/2000 | US6017922 Thermally stable trimetrexates and processes for producing the same |
| 01/25/2000 | US6017920 Antifungal composition for external use being retentive in stratum corneum |
| 01/25/2000 | US6017759 Chimeric infectious bursal disease virus cDNA clones, expression products and vaccines based thereon |
| 01/25/2000 | US6017756 A catalytic rna enzyme, or ribozyme; therapy for hepatitis b |
| 01/25/2000 | US6017728 ribH |
| 01/25/2000 | US6017543 Outer envelope free viral preparation for use in vaccination against and immunotherapy of human immunodeficiency virus |
| 01/25/2000 | US6017542 Nucleotide and amino acid sequences of canine herpesvirus GD and uses therefor |
| 01/25/2000 | US6017539 Multimeric hybrid genes encoding corresponding chimeric protein comprise gene sequence coding for antigenic region of protein from first pathogen linked to gene sequence coding for antigenic region of protein from second pathogen |
| 01/25/2000 | US6017537 Immunological adjuvants comprised of the n-formyl methionyl peptide fmlp used as an adjuvant to provide for an immune response to suboptimal doses of recombinant antigens |
| 01/25/2000 | US6017536 Simian immunodeficiency virus peptides with antifusogenic and antiviral activities |
| 01/25/2000 | US6017532 Porphyromonas gingivalis arginine-specific proteinase |
| 01/25/2000 | US6017531 An extracellular neutral protease and a stabilizer of glyceryl cocoate as a wound healing agent and for debriding necrotic tissue; storage stable enzyme activity at room temperature; burns; cutaneous ulcers; pressure necroses incisional, |
| 01/25/2000 | US6017528 Therapeutic treatment of group A streptococcal infections |
| 01/25/2000 | CA2184005C Novel phosphoramidate and phophorothioamidate oligomeric compounds |
| 01/25/2000 | CA2053231C Novel vitamin d analogues |
| 01/25/2000 | CA2027629C Glycopeptide antibiotics |
| 01/25/2000 | CA2001436C Carboxylic acid derivatives |
| 01/20/2000 | WO2000003030A2 Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species |
| 01/20/2000 | WO2000003016A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 01/20/2000 | WO2000002913A1 Chemotaxis-inhibiting protein of staphylococcus (chips) and its use |
| 01/20/2000 | WO2000002892A1 Novel antibacterial compounds |
| 01/20/2000 | WO2000002881A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 01/20/2000 | WO2000002870A1 Antiviral macrocyclic compounds |
| 01/20/2000 | WO2000002860A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | WO2000002841A1 Water-soluble zinc pyruvates or their hydrates, method for the production thereof and their use |
| 01/20/2000 | WO2000002839A1 Cytokine production and tyrosine kinase inhibitors |
| 01/20/2000 | WO2000002592A1 Pharmaceutical composition containinig gaba analogs and an antiviral agent to treat shingles |
| 01/20/2000 | WO2000002582A2 Treatment of celiac disease with interleukin-15 antagonists |
| 01/20/2000 | WO2000002567A1 Water miscible macrolide solutions |
| 01/20/2000 | WO2000002558A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/20/2000 | WO2000002557A1 Use of an inhibitor of cytochrome p450 optionally combined with an antifungal agent for treating mycoses |
| 01/20/2000 | WO2000002554A1 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies |
| 01/20/2000 | WO2000002523A2 Vaccine against staphylococcus intoxication |
| 01/20/2000 | WO2000002522A2 Anthrax vaccine |
| 01/20/2000 | WO1999059633A8 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 01/20/2000 | WO1999058541A3 Improvements in macrolide production |
| 01/20/2000 | WO1999055347A3 Treatment of papilloma virus infection using a mycobacterium |
| 01/20/2000 | WO1999054954A3 Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections |
| 01/20/2000 | WO1999052515A3 Use of organophosphoric compounds for the therapeutic and preventative treatment of infections |
| 01/20/2000 | WO1999045908A3 Anti-viral uses of leflunomide products |
| 01/20/2000 | WO1999044604A9 Pharmaceutical compositions containing the phospholipase inhibitor sodium [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1h-indol-4-yl]oxy]acetate |
| 01/20/2000 | DE19831710A1 New diacyl-hydrazine derivatives, are integrin inhibitors useful for treating e.g. thrombosis, cardiac infarction, tumors, osteoporosis, inflammation or infection |
| 01/20/2000 | CA2339355A1 Anthrax vaccine |
| 01/20/2000 | CA2337966A1 Vaccine against staphylococcus intoxication |
| 01/20/2000 | CA2337261A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/20/2000 | CA2337258A1 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | CA2336990A1 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies |
| 01/20/2000 | CA2335090A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 01/20/2000 | CA2333923A1 Treatment of celiac disease with interleukin-15 antagonists |
| 01/20/2000 | CA2333898A1 Chemotaxis-inhibiting protein of staphylococcus (chips) and its use |
| 01/19/2000 | EP0972840A2 New attenuated myxoma recombinant virus and its use in the preparation of mixed vaccines against myxomatosis and rabbit hemorrhagic disease |
| 01/19/2000 | EP0972839A1 Insertional mutations in mycobacteria |
| 01/19/2000 | EP0972779A2 Oligonucleotide-polyamide conjugates |
| 01/19/2000 | EP0972778A1 Erythromycin derivatives and methods for the preparation thereof |
| 01/19/2000 | EP0972523A2 Method and compositions for inducing immunity to viruses |
| 01/19/2000 | EP0972054A1 Enhancement of immune response using targeting molecules |
| 01/19/2000 | EP0972048A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 01/19/2000 | EP0972047A2 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination |
| 01/19/2000 | EP0972045A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS) |
| 01/19/2000 | EP0972044A1 Chemokine beta-6 |
| 01/19/2000 | EP0972010A1 Use of the antibacterial active substance triclocarbane in liquid soaps |
| 01/19/2000 | EP0971961A1 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation |
| 01/19/2000 | EP0971923A2 Synthesis of acyclic nucleoside derivatives |
| 01/19/2000 | EP0971908A1 Il-8 receptor antagonists |
| 01/19/2000 | EP0971895A1 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 01/19/2000 | EP0971894A1 Nicotinamide derivatives |
| 01/19/2000 | EP0971889A1 Process for synthesizing carbapenem intermediates |
| 01/19/2000 | EP0971740A2 Fibronectin binding protein compositions, antibodies thereto, and methods of use |
| 01/19/2000 | EP0971739A2 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 01/19/2000 | EP0971738A1 Detoxified mutants of bacterial adp-ribosylating toxins as parenteral adjuvants |
| 01/19/2000 | EP0971734A1 Carbohydrate antigens which immunoreact with polyclonal antisera against h. pylori |
| 01/19/2000 | EP0971726A1 Peptides for inhibiting retroviruses |
| 01/19/2000 | EP0971715A1 Mixtures of at least two reverse transcriptase inhibitors and hydroxycarbamide, in particular for inhibiting retroviral spread |
| 01/19/2000 | EP0728144B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
| 01/19/2000 | EP0654086B1 Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |